C
omplex ventricular arrhythmias (VA) are a major cause of sudden death in patients with structural heart diseases. 1 The prevalence of complex VA, including premature ventricular contractions, is ≈70% in patients with coronary artery disease; 55% in patients with hypertension, valvular disease, or cardiomyopathy without coronary artery disease; and 30% in patients with no cardiovascular disease. 1 The origin of VA may include a variety of mechanisms, including increased automaticity, triggered activity, and scar-based reentry. In structural heart disease, a principal cause of VA is abnormal myocardium (scar), which enables development of arrhythmias by a reentrant mechanism. Current treatment of complex VA and sudden cardiac death, including implantable cardioverter defibrillators, antiarrhythmic medication, and catheter ablation, focus on electrical homogenization of the scar region and have significant limitations, including adverse side effects from medications and procedural risks, such as bleeding and stroke. Furthermore, recurrent implantable cardioverter defibrillators shocks reduce quality of life, can result in post-traumatic stress disorder, and increase mortality 2, 3 ; thus, evolving therapies that target the prevention of VA are necessary. We propose an original approach using naturally occurring, 3-dimensional (3D), printed biocompatible conductive materials for treatment of complex scar-related/reentry-based VA. A highly conductive and flexible biopatch may bypass abnormal areas of slow or failed conduction, thus restoring normal conduction and preventing reentrant dysrhythmia. In this article, we aim to highlight the production of application of such a material in an in vivo canine model.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request.
Conductive Ink Preparation
P3 single-walled carbon nanotubes (SWCNTs; 76.8 mg from Carbon Solutions, Inc, purified with nitric acid, with a bundle diameter ≈4-5 nm; 1.0-3.0 wt% COO − H + ) were added to an aqueous solution of a nonionic, noncytotoxic surfactant Pluronic F127 (10 mL, 0.1 wt%; Sigma-Aldrich, BioReagent). This mixture was heated at 70°C for 8 hours and then sonicated for 16 hours creating a 0.77-wt% homogeneous dispersion of SWCNTs. This dispersion (2 mL) was combined with 2 g (≈2 mL) of nanofibrillated cellulose (NFC) to create an aqueous dispersion (3 wt%, carboxymethylated nanocellulose, endotoxin free, charge density ≈515 μeq/g; Innventia). The dispersion was mixed with the SpeedMixerTM at 2000 rpm twice for 2 minutes each time. The resulting homogeneous ink had an NFC-CNT dry weight ratio of 80/20 and a dry mass concentration of 1.9 wt%.
3D Printing and Creation of Biopatches
A 3D printer (3D Discovery from RegenHU, Switzerland) was used to print 1×1 cm 2 patches with a different pattern density through a piezoelectric microvalve with a 300-μm nozzle. The grid patterns were designed using BioCAD software. They were printed at the dispensing pressure of 20 kPa, with a valve opening time of 1200 μs, with a dosing drop distance of 0.05 mm, and a printing speed of 10 mm/s. We compressed bacterial nanocellulose (BNC; Epiprotect2117; Sweden) films and stretched them on a hydrophobic Teflon tape. At the end, the samples were dried at 110°C for 1 hour to result in 20.2±4.0-μm-thick patches.
Characterization Techniques

Rheology
Rheological properties of the inks were studied using the Discovery HR-2 rheometer with a plate-plate setup (TA Instruments, United Kingdom; aluminum plates with 20 mm diameter; gap between plates, 500 μm). The dependence of ink viscosity on shear rate was analyzed at the range of 0.001 to 1000 −1 shear rates. The measurements of the storage (G′) and loss (G′′) moduli were performed using an oscillatory stress sweep in the 0.1-to 1000-Pa range at the frequency of 1 Hz. These measurements helped to define the linear viscoelastic region and to choose a stress of 10 Pa from the linear viscoelastic region for the oscillation frequency measurements conducted at a frequency range of 0.01 to 20 Hz. To prevent water evaporation, an aqueous solvent trap was used during all the experiments.
Atomic Force Microscopy
The topography and height profiles of the patches were analyzed via a tapping mode using a 10-nm-thin tip under the cantilever (SPM-Bruker Dimension 3100, Micro Masch silicon cantilever NSC 15).
Scanning Electron Microscopy
Scanning electron microscopy images were taken at an acceleration voltage of 3 kV in secondary electron mode
WHAT IS KNOWN?
• Abnormalities in cardiac conduction, including delayed activation or heterogeneous activation, because of cardiac injury can lead to arrhythmias. • Methods of altering normal conduction to prevent arrhythmias generally consist of either altering activation characteristics of the local cellular milieu using drugs or destroying heterogeneously activating cells with ablation.
WHAT THE STUDY ADDS?
• Conductive patches with similar conductivity to human heart muscle can be 3-dimensionally printed in specific patterns in such a way that they can maintain their conductivity, flexibility, and stretchability in dry and wet environments.
• When applied to regions of disrupted cardiac activation, conductive carbon nanotube patches normalize conduction through the region.
(LEO Ultra 55 FEG SEM Zeiss). All the samples were sputter coated with a 10-nm-thick gold layer in a vacuum for 60 seconds (Fine Coat Ion Sputter JFC-1100; JEOL, Ltd, Tokyo, Japan) before microscopy analysis.
Mechanical Tensile Testing
The samples were cut into 3-mm-wide stripes using parallel razor blades and prewetted for 24 hours in PBS. Thickness of the stripes was determined with a digital caliper (Mitutoyo). The measurements were performed using a DMA Q800 (TA Instruments) at a ramp force of 0.5 N/min, relative humidity of 40% to 50%, and temperature of ≈22°C. The samples were mounted between the clamps at ≈15 mm distance with a 0.1-N preload force. For the analysis in a wet state, the samples were continuously rehydrated throughout the experiments. A minimum of 5 samples were used for each test.
Electrical Conductivity
Conductivity measurements were performed along the 3D printed lines on the patch using a 4-point probe system (22°C, Parameter Analyzer-Keithley 4200-SCS). At least 5 different spots were tested in a dry state. For the analysis in a wet state, the probes stayed connected to the same spots on the samples throughout the experiment, and PBS was added to wet the patch.
In Vivo Experiments
Six canine studies were performed with approval under Institutional Animal Care and Use Committee approval (Mayo protocol A00002215-17). Three studies were completed using the CARTO mapping system (Johnson and Johnson, New Brunswick, NJ) and 3 were completed using the Rhythmia mapping system (Boston Scientific, Marlborough, MA).
Anesthesia
All animals were fasted for 12 hours before surgery. They were intubated and maintained on general anesthesia using isoflurane after appropriate induction with ketamine and diazepam during surgery.
Cardiac Access
Throughout the procedure, adequate monitoring for sufficient anesthesia was ensured. A minithoracotomy followed by a small incision in the pericardium was performed to access the epicardium, revealing the beating heart. The anterior ventricular surface of the heart was mapped while the ventricle was paced from a catheter sutured to a superior site on the ventricle ≈1 cm from the anticipated center of the surgical incision. Using a scalpel, a near-full thickness incision was made in the ventricle. Nonconducting pledgits were placed in the incision space to decrease bleeding and increase the likelihood of affecting conduction at the incision site. This area was then remapped using a multipolar mapping catheter; first without the biopatch and then with the biopatch placed over the incision.
Electroanatomical Mapping
After induction, skin surface stickers were applied to the chest wall for electroanatomical mapping (EAM) of the heart. This allows catheter orientation with the magnet placed beneath the operating table. All mapping was done during pacing. Again, the pacing electrode was sutured to the cardiac surface at a location ≈1 cm from the planned incision site such that the distance between the pacing electrode and the edge of the patch once applied over the incision would be ≈0.5 cm. For the CARTO mapping system, high-density epicardial EAM of the ventricle was performed with a PentaRay (Biosense Webster, Diamond Bar, CA) catheter. The PentaRay catheter consists of twenty 1-mm electrodes dispersed over 5 splines with 4 electrodes per spline. The spacing between electrodes is 4-4-4 mm.
For the Rhythmia mapping system, high-density epicardial EAM of the ventricle was performed with an Intellamap Orion (Boston Scientific, Minneapolis, MN) catheter. The Intellamap Orion catheter consists of 64 electrodes dispersed over 8 splines with 8 electrodes per spline. When mapping the epicardium, the cage was not expanded, and the catheter was rolled over the epicardial surface.
For all 6 studies, the ECG was used as the reference. All electrograms were filtered at a bandpass setting of 50 to 500 Hz. The voltage data were analyzed during the procedure to ensure appropriate signal quality and reviewed again postprocedure to ensure appropriate referencing.
Conduction Velocity
Measures of conduction velocity were made on the basis of relative timing of activation of 2 adjacent points mapped on the epicardial surface relative to a fixed reference. Specifically, we selected 2 adjacent points toward just beyond either end of the incision and 2 points adjacent on either side toward the middle of the incision. The absolute distance between the points in millimeters and the difference in relative timing to the fixed reference was computed before making the incision, after making the incision, and after patch application. The velocity was computed as the distance between divided by the difference in relative activation time to the fiducial reference.
Animal Sacrifice
After completion of the procedure, the animals were euthanized by induction of ventricular fibrillation. The heart was excised, and an evaluation of gross pathology of the endocardial and epicardial surfaces of the heart, as well as the specific site where the patches were placed, was performed.
Statistics
For mechanical analysis of BC substrates, calculations of mean and SD were based on the data obtained from 5 samples. For roughness analysis of printed lines and substrates, calculations of mean and SD were based on the data obtained from at least 5 different spots. For comparison of conduction velocity, a 1-way ANOVA was used. Significance was determined based on an α <0.05. If a comparison reached statistical significance, Bonferroni correction was used to correct for type I errors. All statistics were performed in JMP Pro 11 (SAS Institute).
RESULTS
Ink Development and 3D Printing of Conductive Patches
To optimize flow through the printer head, the viscosity of the material was optimized such as to decrease with increasing shear rate ( Figure 1A) . Figure 1B shows how the NFC-based inks rapidly solidify on printing, demonstrated by high storage modulus (G′) and elastic behavior at low oscillation stress (G′ is considerably higher than G′′). Both pure NFC and NFC/SWCNT ink were demonstrated to have well-defined dynamic yield stress (G′=G′′; 217 and 106 Pa, respectively) when elastic behavior evolves into viscous behavior, thus allowing for successful flow through the 3D printer head.
Electrically conductive NFC-SWCNT composite inks were obtained by homogeneous mixing of NFC and SWCNT dispersions as explained previously. For purposes of printing, BNC substrates were developed to have a high degree of roughness (Figure 2 ; Ra=13.6±2.4 nm) and porosity (Figure 3) , to facilitate adhesion of printed NFC-SWCNT patterns. To increase ink-substrate interaction, BNC substrates were prewetted before printing, resulting in a more porous open surface of the substrate ( Figure 3A ) in comparison with a dry substrate ( Figure 3B ). Figure 3C and 3D reveal good adhesion of NFC/SWCNT printed patterns to the BNC substrate. Strong adhesion between printed ink and substrates was meant to ensure patch stability when applied to a moving surface, such as the cardiac silhouette.
Characterization of Conductive Patches
Morphological and topographical features of the printed patterns were evaluated using atomic force microscopy and scanning electron microscopy. Figure 4 shows conductive patterns 3D printed with the NFC-SWCNT ink. Rapid solidification of the ink was achieved by drying and rapidly removing water, which increases the concentration of NFC and SWCNTs in the deposited ink and thus decreases the separation distance between the NFC and SWCNTs.
According to atomic force microscopy images ( Figure 5 ), the topography of the lines is characterized by fairly low aggregation of nanoparticles (NFCs and SWCNTs), demonstrating low surface roughness (Ra=3.4±1.3 nm). Homogeneous dispersion of 20 wt% SWCNTs within the NFC ink makes the ink suitable for printing patterns with electrical conductivity of 4.3·10 −1 S/cm, which increases in the wet state ( Figure 6 ). After an electric field is applied a few times (each time point in Figure 6 corresponds to a 10-s application of an electric field), realignment of SWCNTs takes place inside the viscous hydrogel, and conductivity increases. When material starts to dehydrate or dry after 20 minutes, the viscosity increases and alignment diminishes, with the electrical conductivity of the printed patterns returning to the initial dry value. In turn, flexibility and stretchability of the BNC films is directly related to the dryness, with stiffer and stronger consistency when dry versus greater flexibility and stretchability when wet (Table; Figure 6 ).
In Vivo Studies
High-density EAMs were created in sinus rhythm while paced at a faster heart rate. Three animals were mapped using the CARTO EAM system (Biosense Webster), and 3 were mapped using the Rhythmia mapping system (Boston Scientific). There were more points collected using the Intellamap Orion (Rhythmia) than via mapping with CARTO; however, more points were erroneous and needed to be deleted (2978±214 versus 239±15 points before review The level of statistical significance remained after correction (Figure 8 ). There was a significant difference in the conduction velocity at the center of the incision when comparing baseline control with postincision (P=0.001) and when comparing post-incision with SWCNT-BNC biopatch application over the incision (P=0.0004). Of note, there was no significant difference in conduction velocity when comparing the baseline control with application of the SWCNT-BNC biopatch over the incision (P=0.81). In addition, there was no difference in conduction velocities between either edge and the center of where the incision was placed before incising the tissue or after application of the patch (ie, uniform velocity before surgical disruption and after patch application). There was heterogeneous conduction noted in the surgical incision group between individual canines, which was thought to be secondary to the incision not being transmural and thus allowing for conduction both around and from underneath the incision.
DISCUSSION
Our proof-of-concept study demonstrates that a highly conductive, flexible biopatch, when passively applied to surgically disrupted epicardium, can influence cardiac conduction. The change in activation seen with patch application is provocative and provides a starting point for further research into whether such an approach may be used for more complex regions of disrupted conduction, such as over areas of myocardial scar.
Conductive Biomaterials and Relevance to Cardiac Therapeutics
Myocardial infarctions result in cardiomyocyte death, tissue remodeling, and often a heterogeneous fibrous scar. The scar is believed to preserve tissue integrity, preventing wall rupture after the loss of myocytes; however, the fibrous scar may also result in decreased mechanical contractility, heart failure, and arrhythmogenesis, despite optimal clinical management. [4] [5] [6] Cardiac tissue engineering of patches are thought to be a promising option to help repair postinfarcted hearts. Engineered tissues, however, need to have mechanical and electrical properties similar to native healthy tissue. Therefore, to create engineered patches, many groups utilize CNT/biomaterial composites, coculturing different cell types with the biomaterial. 7 The ultimate goal is to transplant these tissue-engineered patches to replace fibrous scars. It has been suggested that the key to creating an appropriate and effective conductive biomaterial lies in the fabrication of the material. 9 Conductive biomaterials, including conductive polymers, 10 carbon nanotubes, 11 graphene, 12 and nanogold, 13 are all emerging as promising functional materials for biomedical applications. We used functionalized CNTs because of their high dispersibility and hydrophilicity and their resulting biocompatibility, low cytotoxicity, and immunogenicity, which are all necessary for biomedical applications. 14, 15 CNTs are single walled or multiwalled based on the number of graphene sheets or walls forming their structure. SWCNTs have a smaller diameter and thus higher structural stability 16 ; therefore, our research utilized SWCNTs. Furthermore, the low roughness of SWCNT-containing composites leads to lower electrical resistance, 17 and more importantly, it can establish seal resistance with smooth tissue.
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Material Property Considerations
Naturally occurring, commercially available NFC was mixed with SWCNTs in our study to create a unique conductive ink with the ability to increase shape fidelity while maintaining shear-thinning properties, allowing for 3D printing. 19, 20 Charge-stabilized NFC-based structures were previously shown to have no negative effect on cell viability after solidification and drying. 20, 21 To create our biocompatible conductive patches, the ink was printed onto Food and Drug Administration-approved flexible BNC substrates because of its good biocompatibility and tissue integration capability, partly thought to result from the highly hydrated nanofibrils having similar shape, size, and width (70-140 nm) to collagen fibrils found in the extracellular matrix of several tissues. 22 Because of the fact that native BNC is mostly composed of water (99%), it maintains high flexibility while yielding high tensile strength. 23, 24 These properties made BNC a good potential substrate for our experiments. 25, 26 We hypothesized that key features of any patch that could be used to affect cardiac conduction would rely on it being (1) conductive, (2) flexible, (3) printable, and (4) maintain or these properties when wet. We demonstrated that the flexibility element was actually enhanced when wet. The need for stretchability of patches when used for cardiac applications has been supported by others. 17 Part of the reason for the enhanced conductivity in aqueous environments of our patches may have to do with the nature of particle interactions in the NFC-SWCNT material. Ink solidification occurs not because of cross-linking but because of neighboring particles having increasing attractive van der Waals forces when in close proximity to one another. After drying the printed ink at 110°C, the NFC irreversibly agglomerates (hornifies) because of the formation of strong hydrogen bonds. 27 These bonds stay intact even after rewetting, 28 which keeps the NFC/SWCNT prints stable under wet conditions. Therefore, our biopatch is characterized by sufficient electrical conductivity of printed patterns with high mechanical strength and flexibility.
Restoration of Cardiac Conduction
These findings highlight a potential means by which to restructure conduction in a manner that may be reversible and does not depend on further tissue destruction or cause a patient to take potentially arrhythmogenic medications. Currently, the theory behind the treatment of arrhythmias, whether ventricular or atrial, lies in the prem- All data are presented as mean±SD. BNC indicates bacterial nanocellulose.
Figure 7. Electroanatomic mapping.
Top, Gross pathology of normal epicardium, surgically disrupted myocardium with pledgits, and carbon nanotube-printed patch placed over the disrupted myocardium. Middle, Local activation time (LAT) maps under the 3 described conditions. Bottom, Isochronal activation maps. Red indicates early activation, with progressive change to blue/violet indicating later activation. Note: post-incision, there is a region of late activation in the center of the map in the area of the incision. Whereas the baseline map exhibits progressive activation out to the periphery from the pacing site, the postincision map suggests a pathway around the incision. Importantly, note that the isochronal activation map of the post-patch is similar to baseline. Also refer to Movies I-III in the Data Supplement for corresponding propagation videos.
ise of electrical homogenization. 29, 30 Within this theory, it is recognized that scar-related arrhythmias are because of heterogeneous conduction within regions of intermixed slow/rapid conduction. Medications are used to further alter the excitable gap responsible for arrhythmia development. In turn, ablation is performed to destroy tissue throughout the region and effectively homogenize electrical conductivity. However, in both cases, because of effects on normal, seminormal, and abnormal tissue, there is potential to create a proarrhythmic milieu.
One critical issue is that even during scar homogenization, one can actually create scar that results in new, potentially arrhythmogenic circuits. Further, there may be multiple channels of varying conductivity through the region of scar. By using an individualized 3D printed patch with predictable conduction properties, one may be able to stabilize conduction/activation across tissue without the need to destroy the otherwise viable tissue.
Our research supports the premise that, at least with an iatrogenically created incision resulting in disruption of normal conduction, application of an electrically conductive patch may normalize activation. The direct current conductivity for normal cardiac muscle is around 3·10 −3 S/cm, 31 and our conductive biopatches have a conductivity of 4.3·10 −1 S/cm; therefore, the biopatches are more conductive than normal cardiac tissue and should theoretically preferentially conduct energy through the patch rather than through the abnormal cardiac tissue. However, while we hypothesize potential benefit of these patches for eventual application to situations in which scar may contribute to arrhythmogenesis, our study was not specifically structured to prove that we could balance conduction across larger regions (eg, after myocardial infarct or nonischemic fibrotic replacement of myocardium). Thus, further study is required to demonstrate the ability of larger patches to balance conduction across larger scar regions.
Antiarrhythmic Versus Proarrhythmic Potential?
Although the purpose of our experiments was to restore activation across a region of disrupted conduction, the exact effect of a material with more rapid conductivity than myocardium on proclivity toward arrhythmia remains to be seen. In theory, balancing conduction through a region in which heterogeneous activation exists may prevent arrhythmia. However, in as much we can see improved activation characteristics, it is possible by creating even faster conduction paths, that proarrhythmia could result. Thus, future research will need to focus on the arrhythmic potential of such conductive materials.
Theoretical Role in Promoting Myocardial Viability
Utilizing a conductive patch instead of destroying tissue via cardiac ablation may also allow for preservation of the underlying tissue because of the nature of carbon nanotubes. The molecular mechanisms by which carbon nanotubes exert benefits in terms of cardiac repair and conduction have been repeatedly demonstrated in the literature although mechanisms remain unclear. 11, [32] [33] [34] Some authors speculate that the mechanical and electrical properties of carbon nanotubes may create a supportive microenvironment triggering beneficial mechanotransduction signaling. 32 Furthermore, there is significant literature demonstrating cell matrix-induced biomechanical signals playing an important role in regulating cardiac contractility, survival, and repair. 32, 35 Thus, beyond the nonablative scaffold facilitating normalization of conduction through regions of disrupted activation, it is theoretically possible that there may be additional benefits with carbon nanotube patches in terms of promoting cell viability.
Mechanisms of Interaction Between a Conductive Patch and Electrically Active Tissues
One key question is why a conductive patch should be able to allow for direct electrical communication between otherwise electrically separated myocytes. Understanding the interaction and communication of cardiac tissue with biomaterials is complex and involves multiple disciplines, including biology, biophysics, biochemistry, biomaterials, nanotechnology, bioengineering, and applied medicine. It is well established that electron transfer facilitates conduction in carbon-based conductive materials, and ionic transfer facilitates conduction in cardiac tissue. It remains unclear how the 2 systems electrically interact with each other although the potential for such interaction A, Schematic demonstrating the points used to calculate the velocities at the middle of the incision. B, Three points were taken from each animal and averaged and SD calculated. ANOVA was used to assess statistical significance. There is significance seen between the baseline and incision and between incision and application of the patch, but no significance was seen when comparing baseline with patch.
is well documented both in tissue engineering studies and studies of applying acellular conductive materials to electrically conductive tissues. 11, [32] [33] [34] Our study was not specifically structured to address this question, and further research is required to establish mechanistic understanding. It is important to note, however, that other studies have demonstrated conduction from cultured cardiomyocytes or cardiac tissue through conductive biomaterials, thus supporting our findings. Hsiao et al 36 showed that clusters of neonatal rat cardiomyocytes grown on different formulations of aligned composite nanofibers of polyaniline and poly(lactic-co-glycolic acid) beat asynchronously before electrical stimulation but synchronously once attached to a high conductivity mesh. An ex vivo study by He et al 37 placed a conductive polypyrrole-chitosan gelfoam patch between 2 pieces of cardiac tissue and showed the material supported conduction across the isolated cardiac tissue by optical mapping. Furthermore, He showed in vivo surgical implantation of the material for right ventricular outflow tract-created defects led to enhanced conduction velocity by optical mapping compared with nonconductive material. These studies in addition to others looking at chitosan scaffolds in infarcted hearts support the notion that an acellular conductive material may facilitate cardiac conduction.
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Limitations
There are several potential limitations of this study. First, this is an acute study, and chronic sustainability and biologic response from biopatch implantation was not evaluated. The mechanism of cell to material interaction is also unknown as outlined above and requires additional ex vivo and in vitro study to understand. Although we sought to disrupt conduction locally by making a near-transmural incision and using nonconductive material within the incision, this methodology is iatrogenic and not reflective of a normally encountered clinical situation. Furthermore, it should be noted that it cannot be assumed that any line of block was created as we presume that paths of conduction both around and beneath the incision would still be feasible. However, we did demonstrate a change in normal local conduction pattern after the incision based on EAM. Thus, it would stand to reason that the change in activation from post-incision but prepatch placement to postpatch placement was because of the biopatch.
Conclusions
In conclusion, this proof-of-concept study demonstrates the promise of conductive biopatches as a means to restore electrical conduction in abnormal areas of the heart. Future research is required to evaluate potential role in treatment for VA, both associated with scar from myocardial infarctions and possibly nonischemic heterogeneous scar, in addition to treatment of bradycardia, atrioventricular block, and bundle branch block. Furthermore, mechanistic studies to further characterize the myocyte-material interface are necessary.
